Analysis of nebivolol cardioprotective effect on myocardium ultrastructure during regenerative & plastic heart failure in rats
Abstract
toxic reaction with a development of specific manifestations of regenerative & plastic heart failure in rats.
Cardioselective β1-blocker nebivolol reveals evident cardioprotective activity in this heart failure model. It's
confirmed by a considerable reduction of cardiomyocytes cell death processes intensity (mainly apoptosis),
delayed activation of intracellular regeneration signs in the majority of heart muscle cells, structural stabi-
lization of myohematic barrier components, and reduction of intracellular and especially interstitial edema
manifestations.
About the Authors
Ю. КротоваRussian Federation
Д. Хлопонин
Russian Federation
П. Хлопонин
Russian Federation
Т. Архипова
Russian Federation
References
1. Непомнящих Л.М., ЛушниковаЕ.Л., Семенов Д.Е. Регенераторно- пластическая недостаточность серд- ца. Морфологические основы и мо- лекулярные механизмы. - М.: Изд-во РАМН. 2003. 256 с.
2. Семенов Д.Е., Лушникова Е.Л., Не- помнящих Л.М. Особенности антра- циклиновой модели кардиомиопатии: снижение синтеза белка, нарушение внутриклеточной регенерации и без- некротическая элиминация кардио- миоцитов // Бюлл. эксп. биол. 2001. Т. 131. № 5. С. 594-600.
3. Arola O.J., Saraste A., Pulkki K., Kal- lajoki M., Parvinen M., Voipio-PulkkiL.M. Acute doxorubicin cardiotoxic- ity involves cardiomyocyte apoptosis // Cancer Res. 2000. V. 60. P. 1789-1792.
4. Diwakar J. Cardiotoxicity of doxorubi- cin and other anthracycline derivatives// J. Nucl. Cardiol. 2000. Vol. 7. № 1. P. 53-62.
5. Kalay N., Basar E., Ozdogru I. Pro- tective effects of carvedilol against anthracycline-induced cardiomyopathy// J. Am. Coll. Cardiol. 2006. Vol. 48. P. 2258-2262.
6. Minotti G., Menna P., Salvatorelli E., Cairo, G., Gianni L. Molecular advanc- es and pharmacologic developments in antitumor activity and cardiotoxicity // Pharmacol. Rev. 2004. Vol. 56. № 2. P. 185-229.
7. Noori A., Lindenfeld J., Wolgel E.,Ferguson D., Bristow M.R., Lowes B. β-Blockade in adriamycin-induced cardiomyopathy // J. Card. Fail. 2000. Vol. 6. № 2. P. 115-119.
8. Peng X., Chen B., Lim C.C., Sawyer D.B. The cardiotoxicology of anthra- cycline chemotherapeutics: Translating molecular mechanism into preventative medicine // Mol. Interventions. 2005. V. 5. P. 163-171.
9. Reynolds, E.S. The use of lead citrate at high pH as an electron opaque stain in electron microscopy // J. Cell. Biol. 1963. V. 17. № 1. P. 208-212.
10. Shan K., Lincoff A.M. & Young J.B. Anthracycline-induced cardiotoxicity // Ann. Int. Med. 1996. Vol. 125. № 1. P. 47-58.
11. Singal P.K., Iliskovic N. Doxorubicin- induced cardiomyopathy // N. Engl. J. Med. 1998. Vol. 339. P. 900-905.
12. Siveski-Iliskovic N., Kaul N. & Singal P.K. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomy- opathy in rats // Circulation. 1994. Vol. 89. P. 2829-2835.
13. Watson M.L. Staining of tissue sections for electron microscopy with heavy metals // J. Biophys. & Biochem. Cytol. 1958. Vol. 4. P. 475-478.
14. Watson M.L. Staining of tissue sections for electron microscopy with heavy met- als: II. Application of solutions contain- ing lead and barium // J. Biophys. & Bio- chem. Cytol. 1958. Vol. 4. P. 727-730.
Review
For citations:
, , , Analysis of nebivolol cardioprotective effect on myocardium ultrastructure during regenerative & plastic heart failure in rats. Journal Biomed. 2012;1(1):86-92. (In Russ.)